Početna stranicaHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Preth. zaklj. cijena
25,60 €
Dnevni raspon
25,80 € - 25,80 €
Godišnji raspon
21,00 € - 28,80 €
Tržišna kapitalizacija
364,25 mlr. JPY
Prosječna količina
6,00
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
TYO
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(JPY) | kol 2024.info | Godišnja promjena |
---|---|---|
Prihod | 39,65 mlr. | 13,66 % |
Operativni troškovi | 18,75 mlr. | 17,95 % |
Neto dohodak | 4,31 mlr. | −1,33 % |
Neto profitabilnost | 10,87 | −13,18 % |
Zarada po dionici | — | — |
EBITDA | 6,35 mlr. | 20,49 % |
Efektivna porezna stopa | 28,38 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(JPY) | kol 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 122,74 mlr. | −13,22 % |
Ukupna imovina | 350,48 mlr. | 1,79 % |
Ukupne obveze | 74,55 mlr. | 7,74 % |
Ukupni kapital | 275,92 mlr. | — |
Dionice u optjecaju | 73,34 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,01 | — |
Povrat imovine | 3,52 % | — |
Povrat kapitala | 4,46 % | — |
Tok novca
Neto promjena novca
(JPY) | kol 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | 4,31 mlr. | −1,33 % |
Gotovina od poslovanja | — | — |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | — | — |
Neto promjena novca | — | — |
Slobodan tok novca | — | — |
Više
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Osnovano
1847
Sjedište
Web-lokacija
Zaposlenici
2.759